137 related articles for article (PubMed ID: 19023179)
1. Gene expression profiling reveals complex changes in the olfactory bulbectomy model of depression after chronic treatment with antidepressants.
Takahashi K; Saitoh A; Yamada M; Maruyama Y; Hirose N; Kamei J; Yamada M
J Pharmacol Sci; 2008 Nov; 108(3):320-34. PubMed ID: 19023179
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.
Saitoh A; Yamada M; Yamada M; Takahashi K; Yamaguchi K; Murasawa H; Nakatani A; Tatsumi Y; Hirose N; Kamei J
Brain Res; 2008 May; 1208():160-9. PubMed ID: 18381208
[TBL] [Abstract][Full Text] [Related]
3. Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.
Breuer ME; Groenink L; Oosting RS; Westenberg HG; Olivier B
Biol Psychiatry; 2007 Apr; 61(8):990-5. PubMed ID: 17141743
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats.
Breuer ME; Groenink L; Oosting RS; Buerger E; Korte M; Ferger B; Olivier B
Eur J Pharmacol; 2009 Aug; 616(1-3):134-40. PubMed ID: 19549514
[TBL] [Abstract][Full Text] [Related]
5. Effect of newly synthesized 1,2,4-triazino[5,6-b]indole-3-thione derivatives on olfactory bulbectomy induced depression in rats.
Aswar UM; Kalshetti PP; Shelke SM; Bhosale SH; Bodhankar SL
Asian Pac J Trop Biomed; 2012 Dec; 2(12):992-8. PubMed ID: 23593581
[TBL] [Abstract][Full Text] [Related]
6. SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model.
Breuer ME; van Gaalen MM; Wernet W; Claessens SE; Oosting RS; Behl B; Korte SM; Schoemaker H; Gross G; Olivier B; Groenink L
Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):101-6. PubMed ID: 18668225
[TBL] [Abstract][Full Text] [Related]
7. Quercetin suppress microglial neuroinflammatory response and induce antidepressent-like effect in olfactory bulbectomized rats.
Rinwa P; Kumar A
Neuroscience; 2013; 255():86-98. PubMed ID: 24095694
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
Goyal SN; Upadhya MA; Kokare DM; Bhisikar SM; Subhedar NK
Brain Res; 2009 Apr; 1266():45-53. PubMed ID: 19254701
[TBL] [Abstract][Full Text] [Related]
9. Changes in emotional behavior of mice in the hole-board test after olfactory bulbectomy.
Saitoh A; Hirose N; Yamada M; Yamada M; Nozaki C; Oka T; Kamei J
J Pharmacol Sci; 2006 Dec; 102(4):377-86. PubMed ID: 17130673
[TBL] [Abstract][Full Text] [Related]
10. The olfactory bulbectomized rat as a model of depression: The hippocampal pathway.
Morales-Medina JC; Iannitti T; Freeman A; Caldwell HK
Behav Brain Res; 2017 Jan; 317():562-575. PubMed ID: 27633561
[TBL] [Abstract][Full Text] [Related]
11. The olfactory bulbectomy model in mice and rat: one story or two tails?
Hendriksen H; Korte SM; Olivier B; Oosting RS
Eur J Pharmacol; 2015 Apr; 753():105-13. PubMed ID: 25446558
[TBL] [Abstract][Full Text] [Related]
12. Alterations in behavioral responses to dopamine agonists in olfactory bulbectomized mice: relationship to changes in the striatal dopaminergic system.
Takahashi K; Nakagawasai O; Nemoto W; Nakajima T; Arai Y; Hisamitsu T; Tan-No K
Psychopharmacology (Berl); 2016 Apr; 233(7):1311-22. PubMed ID: 26856855
[TBL] [Abstract][Full Text] [Related]
13. Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat.
Uzunova V; Wrynn AS; Kinnunen A; Ceci M; Kohler C; Uzunov DP
Eur J Pharmacol; 2004 Feb; 486(1):31-4. PubMed ID: 14751405
[TBL] [Abstract][Full Text] [Related]
14. The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats.
Torregrossa MM; Isgor C; Folk JE; Rice KC; Watson SJ; Woods JH
Neuropsychopharmacology; 2004 Apr; 29(4):649-59. PubMed ID: 14647482
[TBL] [Abstract][Full Text] [Related]
15. N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: behavioral and biochemical analyses in rats.
Smaga I; Pomierny B; Krzyżanowska W; Pomierny-Chamioło L; Miszkiel J; Niedzielska E; Ogórka A; Filip M
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):280-7. PubMed ID: 22820675
[TBL] [Abstract][Full Text] [Related]
16. Influence of olfactory bulbectomy and subsequent imipramine treatment on 5-hydroxytryptaminergic presynapses in the rat frontal cortex: behavioural correlates.
Grecksch G; Zhou D; Franke C; Schröder U; Sabel B; Becker A; Huether G
Br J Pharmacol; 1997 Dec; 122(8):1725-31. PubMed ID: 9422820
[TBL] [Abstract][Full Text] [Related]
17. The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects.
Breuer ME; Chan JS; Oosting RS; Groenink L; Korte SM; Campbell U; Schreiber R; Hanania T; Snoeren EM; Waldinger M; Olivier B
Eur Neuropsychopharmacol; 2008 Dec; 18(12):908-16. PubMed ID: 18789657
[TBL] [Abstract][Full Text] [Related]
18. Chronic administration of the Y2 receptor antagonist, JNJ-31020028, induced anti-depressant like-behaviors in olfactory bulbectomized rat.
Morales-Medina JC; Dumont Y; Bonaventure P; Quirion R
Neuropeptides; 2012 Dec; 46(6):329-34. PubMed ID: 23103057
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effects of nicotine and transcranial magnetic stimulation in the olfactory bulbectomy rat model of depression.
Vieyra-Reyes P; Mineur YS; Picciotto MR; Túnez I; Vidaltamayo R; Drucker-Colín R
Brain Res Bull; 2008 Sep; 77(1):13-8. PubMed ID: 18582540
[TBL] [Abstract][Full Text] [Related]
20. Butea superba-induced amelioration of cognitive and emotional deficits in olfactory bulbectomized mice and putative mechanisms underlying its actions.
Mizuki D; Qi Z; Tanaka K; Fujiwara H; Ishikawa T; Higuchi Y; Matsumoto K
J Pharmacol Sci; 2014; 124(4):457-67. PubMed ID: 24646653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
